Cite
APA Citation
O'Halloran, J. A., Anstrom, K. J., Kedar, E., McCarthy, M. W., Ko, E. R., Melsheimer, R., Boucher, C., Chang, S., Bozzette, S., & Powderly, W. G. (n.d.). lB1531B. Administration of the TNF-alpha inhibitor, infliximab, reduces mortality in hospitalized patients with COVID pneumonia. Results of a randomized controlled trial. Open forum infectious diseases, 9, . http://access.bl.uk/ark:/81055/vdc_100174899628.0x000005